Monopar Therapeutics — Form 4/A
Filed August 28, 2026 · analyzed by the Insider Agent
4/A
▼ Likely negative
significance 49/100
What the filing says
Director Anderson Raymond (MNPR) sold 3K shares (~$352K) on the open market (47% of holdings). Large sale — ~47% of holdings.
Why this rating
Large sale — ~47% of holdings.
See more from August 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.